Evidence map›Paper›PMID 40182438›Full record

ArticleJournal of maxillofacial and oral surgery2025

Clinicopathological Profile and Outcomes of Mucoepidermoid Carcinoma in Sudan: Analysis of 48 Cases.

Azhari Isam, Ibrahim Elmamoun, Salih Ibrahim, Yousif Eltohami

Abstract read
In one paragraph

Article in Journal of maxillofacial and oral surgery, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Azhari IsamMinistry of Health, Khartoum, Sudan.
Ibrahim ElmamounMinistry of Health, Khartoum, Sudan.
Salih IbrahimMinistry of Health, Khartoum, Sudan.
Yousif EltohamiFaculty of Dentistry, University of Khartoum, Khartoum, Sudan.ORCID 0000-0002-7901-4768

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Mucoepidermoid carcinoma is a prevalent form of salivary gland cancer that affects the head and neck. The condition presents with various symptoms. Histologically, it is classified into grades based on the types of cells and their level of invasion. Surgical intervention is the primary treatment approach with an excellent prognosis. Methodology: This study is a descriptive retrospective cohort hospital-based investigation that aims to examine clinicopathological characteristics and treatment outcomes, including a 5-year survival rate. It utilizes patient records from 2010 to 2021 obtained from the Khartoum Teaching Dental Hospital and the Oral Pathology Lab of the University of Khartoum. Results: In this study, a total of 48 patients were included. The primary symptom reported by the patients was swelling in 20 (41%) individuals. The most common histological classification was low-grade mucoepidermoid carcinoma in 41 (85.4%) patients. Mucoepidermoid carcinoma predominantly affected minor salivary glands, with the buccal mucosa being the most common site in 16 (33.3%) patients. The most commonly performed type of resection was soft tissue resection in 39 (81.3%) cases. Selective supraomohyoid neck dissection was performed in 45 (93.8%) patients. Regarding the treatment outcomes, 43 patients (89.6%) had negative pathological margins, 43 patients did not experience recurrence, and the overall survival rate was 64.6%. Conclusion: The study investigated mucoepidermoid carcinoma and found that the majority of patients had low-grade tumors. Soft tissue resection was the most common surgical procedure performed. The overall 5-year survival rate was 64.6%.

Indexed as

Adjuvant therapyMucoepidermoid carcinomaOverall survival rateRecurrenceSalivary glandsSurgery

Identifiers

PMID40182438
PMCPMC11961828

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.